Hungarian pledge on counterfeit meds

As many as one in eight medicinal products could be fake in low- and middle-income countries, with the figure as high as one in give in Africa, according to a report from the University of North Carolina.

The study, which found that about 14% of the tested products in those countries were counterfeit, contained substandard or even harmful components, or had passed their expiration date, has been quoted by the AIPM, the trade group representing innovative pharmaceutical manufacturers in Hungary, as it outlines actions being taken to combat the situation.